How many institutions held PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

77 institutional investors reported PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Q: What does CUSIP 702712100 represent in this 13F holders report?

CUSIP 702712100 is the security identifier for PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 702712100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 3,182,163
Total 13F shares: 42,200,841
Share change: -591,864
Total reported value: $99,586,412
Price per share: $2.36
Number of holders: 77
Value change: -$2,254,627
Number of buys: 34
Number of sells: 65

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 702712100:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	230%	7,331,999	$22,729,000	—	31 Mar 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	157%	5,009,219	$15,529,000	—	31 Mar 2022	13F
Versant Venture Management, LLC	13F	Company	156%	4,959,769	$15,375,000	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	106%	3,375,000	$10,463,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	103%	3,292,792	$10,208,000	—	31 Mar 2022	13F
New Leaf Venture Partners, L.L.C.	13F	Company	78%	2,497,922	$7,744,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	60%	1,913,880	$5,933,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	55%	1,734,894	$5,378,000	—	31 Mar 2022	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	39%	1,235,869	$3,831,000	—	31 Mar 2022	13F
Erste Asset Management GmbH	13F	Company	32%	1,020,800	$3,161,690	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	24%	777,430	$2,410,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	24%	775,900	$2,405,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	24%	760,352	$2,357,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	21%	663,308	$2,057,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	20%	645,311	$2,000,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	16%	524,300	$1,625,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	16%	513,241	$1,591,000	—	31 Mar 2022	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	13%	400,000	$1,240,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	12%	378,160	$1,172,000	—	31 Mar 2022	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	11%	356,000	$1,104,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	10%	322,323	$1,000,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	9.5%	300,732	$932,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	7.8%	247,190	$767,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	7.5%	238,720	$740,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	7.2%	227,623	$706,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	6.3%	201,445	$622,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	6.3%	198,891	$616,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	5.3%	169,517	$526,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	5%	160,259	$496,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	4.6%	147,545	$458,000	—	31 Mar 2022	13F
IndexIQ Advisors LLC	13F	Company	4.1%	129,561	$402,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	4%	128,397	$398,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	4%	128,375	$398,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	3.7%	117,161	$363,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	3.6%	116,100	$360,000	—	31 Mar 2022	13F
Laurion Capital Management LP	13F	Company	3.6%	114,862	$356,000	—	31 Mar 2022	13F
GREAT POINT PARTNERS LLC	13F	Company	3.6%	113,900	$353,000	—	31 Mar 2022	13F
Jill M. Quigley	3/4/5	Chief Operating Officer	— mixed-class rows	399,988 mixed-class rows	$338,849	—	08 Dec 2021	3/4/5
Lynx1 Capital Management LP	13F	Company	3.3%	105,504	$327,000	—	31 Mar 2022	13F
XTX Topco Ltd	13F	Company	3%	94,309	$292,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	2.7%	87,070	$270,000	—	31 Mar 2022	13F
ALGERT GLOBAL LLC	13F	Company	2.5%	79,470	$246,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	2.3%	71,856	$223,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	2.1%	68,039	$211,000	—	31 Mar 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	2%	63,681	$206,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	2%	63,107	$196,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	1.9%	59,521	$184,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	1.9%	59,500	$184,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.6%	52,346	$163,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	1.5%	46,558	$144,000	—	31 Mar 2022	13F

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2022

As of 30 Jun 2022, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,200,841 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Frazier Life Sciences Management, L.P., Versant Venture Management, LLC, New Leaf Venture Partners, L.L.C., Deep Track Capital, LP, VANGUARD GROUP INC, Woodline Partners LP, BlackRock Inc., HIGHLINE CAPITAL MANAGEMENT, L.P., and Erste Asset Management GmbH. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-22

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.